Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications

Clinical Chemistry

Volumn 46, Issue 4, 2000, Pages 461-468

  Roberts, William L ^a,d   Sedrick, Rachel ^b   Moulton, Linda ^b   Spencer, Anthony ^c   Rifai, Nader ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE PHASE RESPONSE; ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; AUTOMATION; BLOOD SAMPLING; CLINICAL LABORATORY; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; PROGNOSIS; STANDARDIZATION;

EID: 0034034469     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.4.461     Document Type: Article

References (29)

1. 1. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999;10: S9-12.
2. 2. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999;37:495-503.
3. 3. Schalkwijk CG, Poland DCW, van Dijk W, Kok A, Emeis JJ, Drager AM, et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 1999;42:351-7.
4. 4. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8.
5. 5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
6. 6. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results of the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
7. 7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
8. 8. Ridker PM, Glynn RJ, Hennekens CH. C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11.
9. 9. Ridker PM, Buring JE, Shin J, Matias M, Hennekens CH. Prospective study of the C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
10. 10. Koenig W, Sund M, Frohlich M, Fischer H-G, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999;99:237-42.
11. 11. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
12. 12. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6.
13. 13. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
14. 14. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, Gioffre PA. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998;82:515-8.
15. 15. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-60.
16. 16. de Winter RJ, Bholasingh R, Lijmer JG, Koster RW, Gorgels JPMC, Schouten Y, et al. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction. Cardiovasc Res 1999;42:240-5.
17. 17. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, et al. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137: 346-51.
18. 18. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
19. 19. Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998;44:1358-61.
20. 20. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45: 2136-41.
21. 21. Kringle RO, Bogovich M. Statistical procedures. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia: WB Saunders, 1999:303-4.
22. 22. Claus DR, Osmand AP, Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976;87:120-8.
23. 23. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981;117:13-23.
24. 24. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43: 52-8.
25. 25. Hak AE, Stehouwer CDA, Bots ML, Polderman KH, Schalkwijk CG, Westendrop ICD, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vase Biol 1999;19:1986-91.
26. 26. Eda S, Kaufmann J, Molwitz M, Vorberg E. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease. Scand J Clin Lab Investig 1999;50(Suppl 230):32-5.
27. 27. Ridker PM, Hennekens CH, Rifai N, Buring J, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-6.
28. 28. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study. Circulation 1999;100:717-22.
29. 29. WHO Expert Committee on Biological Standardization, 37th report. WHO Technical Report Series 760. Geneva: WHO, 1987: 21-2.